Robots pasivos para la rehabilitación de accidentes cerebrovasculares: un estudio de viabilidad
Robots pasivos para la rehabilitación de accidentes cerebrovasculares
The purpose of this study is to examine the feasibility and effectiveness of a novel, multimodal approach that combines passive devices with noninvasive neuromuscular stimulation for upper extremity rehabilitation after stroke.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
About 800,000 individuals suffer from a stroke every year in the United States. The majority of stroke survivors often experience lingering deficits in upper extremity function. High-end robotic devices can improve outcomes and clinical productivity; however, these devices are expensive and bulky, making them not practical for many clinical or home environments. This study aims to evaluate the feasibility of low-cost non-motorized devices for stroke rehabilitation in a long-term intervention. The intervention will involve training with a table-top, semi-passive (i.e., no motors) exercise equipment called SepaRRo and commonly-used neuromuscular stimulation. The stimulation will be provided during functional activities using a custom controller (NeuRRoFES) to trigger stimulation. These instruments are designed to provide flexible, compliant assistance/resistance to improve upper extremity function and can be used in a home setting. The study will measure technical feasibility (e.g., qualitative survey, adherence, time on task, retention, ability to perform tasks) as well as clinical feasibility (i.e., changes in biomechanical, neurophysiological, and functional measures) of an intervention with these devices in stroke survivors. The findings aim to support the development of affordable, home-use rehabilitation systems for stroke patients.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Chandramouli Krishnan, PT, PhD
- Número de teléfono: 7349364031
- Correo electrónico: mouli@umich.edu
Copia de seguridad de contactos de estudio
- Nombre: Thomas E Augenstein, PhD
- Número de teléfono: 7342320898
- Correo electrónico: tomaugen@umich.edu
Ubicaciones de estudio
-
-
Michigan
-
Ann Arbor, Michigan, Estados Unidos, 48108
- Reclutamiento
- University of Michigan - NeuRRo Lab
-
Investigador principal:
- Chandramouli Krishnan, PT PhD
-
Contacto:
- Thomas E. Augenstein, PhD
- Número de teléfono: (734) 936-4031
- Correo electrónico: tomaugen@umich.edu
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age 18 to 75 years;
- Ischemic or hemorrhagic stroke confirmed by CT, MRI, or clinical criteria;
- No major deficits of sensation or proprioception;
Exclusion Criteria:
- Bilateral stroke
- Unable to think clearly and remember (Mini-Mental State Exam score < 22 and miniMOCA < 8);
- Uncontrolled Diabetes or Hypertension;
- Severe limitations of joint range of motion that will lead to inability of testing
- Severe spasticity and joint contractures that will lead to inability of testing
- Complete paresis with no possible movements
- Severe aphasia
- Any other medical condition that will significantly impact the study results
- Unable to obtain reliable motor evoked potentials
- Are pregnant or are actively trying to conceive
- Have a recent history of repeated fainting spells or syncope.
- Have a recent history of seizure (epilepsy) while on anti-seizure medication
- Have a recent history of skull fracture/head injury
- Have metal implants in the skull
- Have cardiac pacemakers
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Viabilidad del dispositivo
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Robotic Intervention
Participants will receive upper extremity rehabilitation using SepaRRo and NeuRRoFES 2-5 times per week for 2-6 weeks |
Participants will perform functional movements (e.g., reach for targets) with their extremities. During movements, the devices will be used to assist or resist their motion. Participants may receive biofeedback of their movements to better engage them in training. Participants may receive assistance from the devices (including neuromuscular stimulation) and/or their less-impaired limb. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Device Survey For Feasibility
Periodo de tiempo: Post-intervention (immediately following last session of intervention)
|
Subjective feedback regarding feasibility of the device for training |
Post-intervention (immediately following last session of intervention)
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Retention
Periodo de tiempo: Post-intervention (immediately following last session of intervention)
|
Measure of how many participants completed intervention |
Post-intervention (immediately following last session of intervention)
|
|
Adherence
Periodo de tiempo: Post-intervention (immediately following last session of intervention)
|
Measure of percentage of sessions completed |
Post-intervention (immediately following last session of intervention)
|
|
Upper extremity Fugl-Meyer Score
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively.
|
Changes in upper extremity Fugl-Meyer score from before the intervention (from baseline) to after its completion using publicly available scoring sheets. The Fugl-Meyer score is a measure of functional impairment and runs from 0 to 66 points, with higher numbers reflecting better outcome. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively.
|
|
Reachable workspace
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in reachable workspace from before the intervention (from baseline) to after its completion). The reachable workspace area will be measured with SepaRRo obtained from optical encoders mounted in the device. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Voluntary hand opening
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in voluntary ability to open the hand from before the intervention (from baseline to after its completion). Voluntary hand opening will be measured with motion capture equipment. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Action Research Arm Test Score
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in the Action Research Arm Test Score from before the intervention (from baseline) to after its completion using publicly available scoring sheets. The Action Research Arm Test is a measure of arm functional ability and runs from 0 to 57 points, with higher numbers reflecting better outcome. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Box and Block (BBT)
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in functional measure of arm disability (BBT) from before the intervention (from baseline) to after its completion using publicly available scoring sheets. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Hand Strength
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in force produced by the hand from before the intervention (from baseline) to after its completion as measured by force production recorded with a dynamometer |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Arm strength
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in force produced by the arm from before the intervention (from baseline) to after its completion as measured by force production recorded with a dynamometer |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Muscle coordination
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in muscle coordination of the upper extremity muscles as measured using surface electromyography between before the intervention (from baseline) to after its completion. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Joint coordination
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in coordination of the upper extremity joints as measured motion capture between before the intervention (from baseline) to after its completion. |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
|
Corticospinal excitability
Periodo de tiempo: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Changes in corticospinal excitability of the upper extremity muscles as measured using surface electromyography and transcranial magnetic stimulation between before the intervention (from baseline) to after its completion |
Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Chandramouli Krishnan, PT, PhD, University of Michigan
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- HUM00087962
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .